Corsair Capital Management »

Vyne Therapeutics shares owned by Corsair Capital Management

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Corsair Capital Management from 13F filings

Historical chart of Corsair Capital Management investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Corsair Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Corsair Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $17k 50k 0.34
2025-06-30 $17k 10k 1.65

More positions owned by Corsair Capital Management

Vertiv Holdings Com Cl A (VRT)
Composecure Com Cl A (CMPO)
Laureate Education Common Stock (LAUR)
Composecure Call Call Option
Limbach Hldgs (LMB)
Api Group Corp Com Stk (APG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Mirion Technologies Com Cl A (MIR)
Spx Corp (SPXC)
Godaddy Cl A (GDDY)
Aon Shs Cl A (AON)
Microsoft Corporation (MSFT)
Vertiv Holdings Call Call Option
Resolute Hldgs Mgmt (RHLD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Corsair Capital Management

Top funds holding Vyne Therapeutics

Baker Bros. Advisors
Acorn Capital Advisors
Shay Capital
Acadian Asset Management
Ikarian Capital
Two Sigma Investments
Vanguard Group
Jane Street
Geode Capital Management
Boothbay Fund Management
Bridgeway Capital Management
Susquehanna International
Two Sigma Advisers
Corsair Capital Management
Rangeley Capital

View all funds holding Vyne Therapeutics